ArticleBMC complementary and alternative medicine2016

Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model.

Hye-Youn Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.